1. Walker, U.A., et al., Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database. (0003-4967 (Print)).
2. Hughes, M., et al., Prediction and impact of attacks of Raynaud's phenomenon, as judged by patient perception. (1462-0332 (Electronic)).
3. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a canadian national survey;Bassel;Rheumatology,2011
4. The patient experience of Raynaud's phenomenon in systemic sclerosis;Pauling;Rheumatology,2018
5. Herrick, A.L., Pathogenesis of Raynaud's phenomenon. (1462-0324 (Print)).